• R-Biopharm AG
  • Contact
  • Media
  • Online Seminars
  • Events
Languages
  • Nederlands
  • Italiano
  • Franรงais
  • Deutsch
  • Espaรฑol
  • English
Subscribe
  • Start
  • Diagnostics
    • Allergology
    • Autoimmunity
    • Bacteriology
    • Gastroenterology
    • Human genetics
    • Mycology
    • Parasitology
    • Tuberculosis
    • Virology
    • Syndromic Testing
  • Indication
    • Allergies
    • Hospital acquired infections & drug resistance
    • Gastrointestinal infections
    • Dermatological Infections
    • Respiratory infections
    • STI & UTI
    • Genetic predisposition
    • Therapeutic drug monitoring
    • Vector-borne infections
  • Technologies
    • Array
    • Blots
    • ELISA
    • PCR
    • Rapid tests
    • Quality Assessment Products
    • MT-PCR
  • Systems
  • Product Finder
  • News
  • Shop
A Division of the R-Biopharm Group
  • Start
  • Diagnostics
    • Allergology
    • Autoimmunity
    • Bacteriology
    • Gastroenterology
    • Human genetics
    • Mycology
    • Parasitology
    • Tuberculosis
    • Virology
    • Syndromic Testing
  • Indication
    • Allergies
    • Hospital acquired infections & drug resistance
    • Gastrointestinal infections
    • Dermatological Infections
    • Respiratory infections
    • STI & UTI
    • Genetic predisposition
    • Therapeutic drug monitoring
    • Vector-borne infections
  • Technologies
    • Array
    • Blots
    • ELISA
    • PCR
    • Rapid tests
    • Quality Assessment Products
    • MT-PCR
  • Systems
  • Product Finder
  • News
  • Shop

Hospital aquired infections

Home ยป Indication ยป Hospital aquired infections
In the hospital, there is a dangerous visitor: What are the most recent research on Clostridium difficile?

In the hospital, there is a dangerous visitor: What are the most recent research on Clostridium difficile?

The bacteria Clostridium difficile colonizes every human intestine, although it may be harmful for those with compromised immune systems. It is becoming increasingly prevalent in hospitals. What [...]

READ MORE
Clostridium difficile: 10 tips for prevention

Clostridium difficile: 10 tips for prevention

The intestinal bacterium Clostridium difficile is one of the most common causes of nosocomial infections. Patients whose intestinal flora is disrupted due to the use of antibiotics are [...]

READ MORE
Clostridium difficile: Detect infections with certainty

Clostridium difficile: Detect infections with certainty

Clostridium difficile is one of the most frequent pathogens in nosocomial infections โ€“ but in spite of this many people have never heard of it. Since November is officially โ€œClostridium [...]

READ MORE
More efficient and flexible: RIDAยฎGENE real-time PCR kits in the new format

More efficient and flexible: RIDAยฎGENE real-time PCR kits in the new format

The new generation of the RIDAยฎGENE multiplex real-time PCR kits offers a number of improvementsโ€”and makes molecular laboratory diagnostics even more efficient and flexible.

READ MORE
Legionella and mycoplasma pneumoniae: New RIDAยฎGENE products for detection of atypical CAP bacteria (en)

Legionella and mycoplasma pneumoniae: New RIDAยฎGENE products for detection of atypical CAP bacteria (en)

Community-acquired pneumonia (CAP) is the most common fatal infectious disease in western countries. Bacteria are the most common pathogens causing CAP, where one differentiates between typical [...]

READ MORE

Clinical Diagnostics

A division of R-Biopharm AG
Subscribe to our newsletter
Company information
  • R-Biopharm AG
  • An der Neuen BergstraรŸe 17
    64297 Darmstadt, Germany
  • +49 (0) 61 51 - 81 02-0
  • +49 (0) 61 51 - 81 02-40
  • info@r-biopharm.de
  • www.r-biopharm.com
Copyright All Rights Reserved ยฉ 2025
  • Imprint
  • Privacy policy
  • GTCs
  • GTCs (Purchase)

Start typing and press Enter to search

TWEST SIS